Robert Torray - Torray Investment Partners
Holding/activity history for Krystal Biotech, Inc. (KRYS)
← All KRYS superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 12,032 | 0.49 | Add 0.39% | <0.01 | $235.60–298.30 · VW $265.68i | $3,108,106 | SEC |
| 2025 Q4 | 11,985 | 0.45 | Add 0.71% | <0.01 | $179.19–265.92 · VW $213.09i | $2,954,782 | SEC |
| 2025 Q3 | 11,901 | 0.29 | Add 2.83% | <0.01 | $130.50–183.58 · VW $151.98i | $2,100,884 | SEC |
| 2025 Q2 | 11,574 | 0.23 | Buy | 0.23 | $122.80–176.73 · VW $143.23i | $1,590,962 | SEC |
Price snapshot:
Current price$363.44
Avg. buy price$139.76
+/- since buy160.05%
52-week low$130.50
52-week high$382.54